INTRONA MARTINO

Buracchi, C., Belotti, D., Moretti, A., Calabretta, L., Risca, G., Capelli, C., et al. (2023). Deep immunophenotypic characterization of CARCIK-CD19 pre-infusion cellular product by advanced multiparametric flow cytometry. Intervento presentato a: ESLHO Symposium, Salamanca, Spain. Detail

Carugno, A., Di Buduo, A., Perna, S., Barile, M., Sena, P., Introna, M. (2023). Epidemiological, Phenotypical, Histological and Genetic Characteristics of Patients with Multiple Melanomas: Study of 108 patients at ASST Papa Giovanni XXIII, Bergamo. Intervento presentato a: 1st Annual PhD Conference in Biomedical Sciences, Monza, Italia. Detail

Gotti, E., Tettamanti, S., Zaninelli, S., Cuofano, C., Cattaneo, I., Rotiroti, M., et al. (2022). Optimization of therapeutic T cell expansion in G-Rex device and applicability to large-scale production for clinical use. CYTOTHERAPY, 24(3 (March 2022)), 334-343 [10.1016/j.jcyt.2021.11.004]. Detail

Capelli, C., Frigerio, S., Lisini, D., Nava, S., Gaipa, G., Belotti, D., et al. (2022). A comprehensive report of long-term stability data for a range ATMPs: A need to develop guidelines for safe and harmonized stability studies. CYTOTHERAPY, 24(5), 544-556 [10.1016/j.jcyt.2021.12.004]. Detail

Rotiroti, M., Buracchi, C., Arcangeli, S., Galimberti, S., Valsecchi, M., Perriello, V., et al. (2020). Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System. MOLECULAR THERAPY, 28(9), 1974-1986 [10.1016/j.ymthe.2020.05.021]. Detail